The Diabetes Atlas, third edition, provides the latest estimates for diabetes and IGT prevalence for 215 countries and territories. It includes new topics not covered in earlier editions including mortality, medication use and mental health. To order: www.idf.org/bookshop.
Content in the e-Atlas is in the process of being updated to include the latest estimates of diabetes prevalence for 2007, revised forecasts for 2025, and the latest information on many topical issues, which were recently published in the Diabetes Atlas, third edition. Estimates currently available on the e-Atlas are for 2003 and 2025 as published in the Diabetes Atlas, second edition.
New features to be introduced soon will include more interactive maps and individual profiles of 215 countries and territories.
Download free:
Executive Summary of the Diabetes Atlas, second edition
Le résumé de la seconde édition du Diabetes Atlas
El extracto de la segunda edición del Diabetes Atlas
Some 246 million people worldwide have diabetes in 2007. It is now one of the most common non-communicable diseases globally. Diabetes is the fourth or fifth leading cause of death in most developed countries and there is substantial evidence that it is epidemic in many developing and newly industrialized nations.
Complications from diabetes, such as coronary artery and peripheral vascular disease, stroke, diabetic neuropathy, amputations, renal failure and blindness are resulting in increasing disability, reduced life expectancy and enormous health costs for virtually every society. Diabetes is certain to be one of the most challenging health problems in the 21st century.
This version of the IDF e-Atlas has been made possible thanks to the generous support of Merck & Co, Inc, Whitehouse Station, NJ, USA.